Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Reed

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Memorias Do Instituto Oswaldo Cruz|May 1, 1997
Chagas disease in Ecuador: evidence for disease transmission in an Indigenous population in the Amazon regionM Chico, C Sandoval, A Guevara, et al.
The Journal of Experimental Medicine|January 1, 1992
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infectionJ S Silva, P J Morrissey, K H Grabstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 1992
Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruziJ M Burns, W G Shreffler, D E Rosman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1995
Visceral leishmaniasis in a new ecological niche near a major metropolitan area of BrazilS Cunha, M Freire, C Eulalio, et al.
The Journal of Experimental Medicine|June 13, 1998
Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cellsD M Lewinsohn, M R Alderson, A L Briden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Characterization of responses of normal human T cells to Trypanosoma cruzi antigensM R Piuvezam, D M Russo, J M Burns, et al.
Immunity|March 1, 1996
CD40 ligand is required for protective cell-mediated immunity to Leishmania majorK A Campbell, P J Ovendale, M K Kennedy, et al.
Infection and Immunity|May 16, 2002
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c miceA Campos-Neto, J R Webb, K Greeson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
IL-10 mediates susceptibility to Trypanosoma cruzi infectionS G Reed, C E Brownell, D M Russo, et al.
The Journal of Experimental Medicine|December 1, 1987
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gammaS G Reed, C F Nathan, D L Pihl, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Memorias Do Instituto Oswaldo Cruz|May 1, 1997
Chagas disease in Ecuador: evidence for disease transmission in an Indigenous population in the Amazon regionM Chico, C Sandoval, A Guevara, et al.
The Journal of Experimental Medicine|January 1, 1992
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infectionJ S Silva, P J Morrissey, K H Grabstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 1992
Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruziJ M Burns, W G Shreffler, D E Rosman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1995
Visceral leishmaniasis in a new ecological niche near a major metropolitan area of BrazilS Cunha, M Freire, C Eulalio, et al.
The Journal of Experimental Medicine|June 13, 1998
Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cellsD M Lewinsohn, M R Alderson, A L Briden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Characterization of responses of normal human T cells to Trypanosoma cruzi antigensM R Piuvezam, D M Russo, J M Burns, et al.
Immunity|March 1, 1996
CD40 ligand is required for protective cell-mediated immunity to Leishmania majorK A Campbell, P J Ovendale, M K Kennedy, et al.
Infection and Immunity|May 16, 2002
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c miceA Campos-Neto, J R Webb, K Greeson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
IL-10 mediates susceptibility to Trypanosoma cruzi infectionS G Reed, C E Brownell, D M Russo, et al.
The Journal of Experimental Medicine|December 1, 1987
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gammaS G Reed, C F Nathan, D L Pihl, et al.
Pageof 17